<DOC>
	<DOCNO>NCT01734525</DOCNO>
	<brief_summary>This prospective study aim test strategy early initiation antifungal agent patient admit intensive care unit ( ICUs ) risk invasive candidiasis . Score system develop identify group high risk development candidemia/invasive candidiasis ICU . These score system use clinical information without data Candida colonization , show reasonable correlation candidemia/invasive candidiasis . More recently , biomarker - detection 1,3-beta-D-glucan serum - test early diagnosis candidiasis . The incorporation biomarkers beta-D-glucan could help clinician select group high risk candidemia , despite fact test may give false-positive result , negative predictive value could great help . Likewise , analyze kinetics biomarkers patient candidemia/invasive candidiasis would help define usefulness monitoring treatment . Therefore , objective study : 1 . To assess frequency positive biomarkers ICU patient high risk develop invasive candidiasis/candidemia ; 2 . To evaluate kinetics positive biomarkers initiation antifungal therapy patient candidemia ; 3 . To test strategy early discontinuation antifungal therapy base repeatedly negative blood culture 1,3 beta-D-glucan serum .</brief_summary>
	<brief_title>A Pilot Study Use Biomarkers Early Treatment Invasive Candidiasis Intensive Care Unit ( ICU ) Patients</brief_title>
	<detailed_description>Entry criterion : In ICU &gt; 2 day AND systemic antibiotic &gt; 2 day OR central venous catheter &gt; day AND least two follow : total parenteral nutrition , dialysis , surgery , pancreatitis , receipt corticosteroid , receipt immunosuppressive agent . In addition , patient must clinical sign infection ( either one follow ) : fever , hypothermia , hypotension , unexplanied acidosis , unexplained elevation C-reactive protein . Eligible patient enrol sign informed consent blood obtained culture determination 1,3 beta-D-glucan serum level 3 day , start anidulafungin IV . If test negative , anidulafungin discontinue day 4 . If 1,3 beta-D-glucan positive ( &gt; 80 pg/ml ) / blood culture positive Candida specie , anidulafungin continue &gt; 14 day . Blood oe collect determination 1,3 beta-D-glucan day 7 , 10 , 14 , 17 , 21 , 24 28 .</detailed_description>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidemia</mesh_term>
	<mesh_term>Candidiasis , Invasive</mesh_term>
	<mesh_term>Anidulafungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>In ICU &gt; 2 day AND Systemic antibiotic day 13 ICU OR Central venous catheter day 13 ICU AND least 2 : Total parenteral nutrition day 13 ICU Any dialysis day 13 ICU Major surgery 7 day admission ICU Pancreatitis 7 day admission ICU Use corticosteroids least 3 day 7 day admission Use immunosuppressive agent 7 day admission ICU In addition , patient must least one follow : Fever ( axillary temperature &gt; 37.5 oC ) Hypothermia ( axillary temperature &lt; 35 oC ) Hypotension Unexplained acidosis Unexplained elevation Creactive protein Antifungal &gt; 3 day Allergy echinocandin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>candidemia</keyword>
	<keyword>intensive care unit</keyword>
	<keyword>1,3 beta-D-glucan</keyword>
</DOC>